Dr. Lance A. Liotta is currently Co-Director of the Center for Applied Proteomics and Molecular Medicine. Dr.Lance A. Liotta and Dr.Emanuel F. Petricoin III founded the Center for Applied Proteomics and Molecular Medicine (CAPMM) in 2005. CAPMM is committed to improved, early disease diagnosis; developing individualized and more effective therapies; and creating a new paradigm for personalized patient care. The primary emphasis of disease research is cancer, but new therapies and diagnostics developed in the center apply to cardiology, diabetes, and obesity, as well as liver, ocular, neurodegenerative, and infectious diseases.

Dr. Lance A. Liotta's areas of interest includes Biomedical and Nanoscience.